Advertisement
All
>
Persons > Northern Europe
Please find below persons from Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as related to organisations from these countries.Total search results: 4146 | Ordered by Person (ascending)
1 2 3 ... 27 28 29 ... 40 41 42
Person | Position | Organisation (Group) | Country |
---|---|---|---|
Mørk, Alejandra (KLIFO 2008– Owner + CEO) | Chief Executive Officer (CEO) | KLIFO (Group) | Denmark |
Nagle, Ashley (Remedy Biologics 202105– VP Business Development before Domain Therapeutics) | Business Development Manager / Strategy Manager | Remedy Biologics Ltd. (RemedyBio) | Ireland, Republic of |
Nagle, Richard (Immune Regulation 2018–202003 CEO LEFT 3/20) | Chief Executive Officer (CEO) | Immune Regulation (Group) | United Kingdom (GB) |
Nagy, Thomas (21st.BIO 202112 COO before Novozymes) | Chief Operating Officer (COO) | 21st.BIO A/S | Denmark |
Najera, Isabel (Virion Biotherapeutics 201809– CSO before Roche sind 1999) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Virion Biotherapeutics Ltd. | United Kingdom (GB) |
Nalliah, Ravi (TrakCel 202002– Chief Strategy Officer before CEO + Co-Founder) | Chief Executive Officer (CEO) | TrakCel (Group) | United Kingdom (GB) |
Nandakumar, Anandkumar (Theragenix 202210– CEO + Co-Founder) | Chief Executive Officer (CEO) | Theragenix Ltd. | United Kingdom (GB) |
Narla, Goutham (Univ Michigan 202010 Professor + Rappta Therapeutics 202010 CSO + Co-Founder) | Professor | University of Michigan (U-M) | United States (USA) |
Nathan, Jacob (Epoch Biodesign 202206 CEO + Co-Founder) | Chief Executive Officer (CEO) | Epoch Biodesign Ltd. | United Kingdom (GB) |
Naughton, Yvonne (Sanofi 201604 Head of External Science + Partnering UK + Ireland) | Business Development Manager / Strategy Manager | Sanofi (Group) [since May 2011] | France |
Nauntofte, Birgitte (Novo Group 202012 CEO of Novo Nordisk Foundation) | n. a. | Novo Group (Group) | Denmark |
Nauska, Esa (Orion Corporation 201205 Director, Industrialisation + Contract Manufacturing) | President/Director/Head Business Group/Unit/Division | Orion Corporation (Group) | Finland |
Naval, Jordi (InProTher 202102–Biocat 202003 CEO) | Chief Executive Officer (CEO) | InProTher ApS | Denmark |
Neal, Matthew (Consilium Strategic Communications 201602) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
Neal, Nathan (Grant Instruments 200812 Director Sales) | Sales Manager / Marketing Manager | Grant Instruments (Group) | United Kingdom (GB) |
Needham, Miles (FRP Advisory 201707) | n. a. | FRP Advisory LLP | United Kingdom (GB) |
Nef, Patrick (Xytis 200511– CSO + CBO before Faust Pharmaceuticals CEO before Roche) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Xytis (Group) | United Kingdom (GB) |
Neil, Madeleine (Uppsala BIO 201109 Director of Communications) | Public Relations Manager / Investor Relations Manager | Uppsala BIO | Sweden |
Nell, Peter (Mammoth Biosciences 202001c– CBO before Co-Founder of Casebia) | Chief Business Officer (CBO) | Mammoth Biosciences Inc. | United States (USA) |
Nellemann Pedersen, Michael (PKA 202206 Chief Investment Officer) | Investment Manager | PKA Pension Fund (DK) | Denmark |
Nelson, Adam (Univ Leeds 201302 Professor of Chemical Biology + Member of Astbury Centre) | Professor | University of Leeds | United Kingdom (GB) |
Neophytou, Savvas (Deepbridge Capital 202205– Partner + Head of Life Sciences) | Partner (venture partner) | Deepbridge Capital LLP | United Kingdom (GB) |
Nessi, Claudio (Omega Funds 202211 before NeoMed Management 201309) | Investment Manager | Omega Funds (Group) | United States (USA) |
Neubauer, Stefan (Univ Oxford 201304 Prof + Non-executive Director of Perspectum Diagnostics) | Professor | University of Oxford | United Kingdom (GB) |
Neville, Lindsey (Consilium 201805) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
Nevin-Ridley, Katrina (United Kingdom (govt) 201506 PR Manager at Genomics England Ltd) | Public Relations Manager / Investor Relations Manager | United Kingdom (GB) (govt) | United Kingdom (GB) |
Newble, David (TTP Group 201506– Managing Director of TTP Labtech before CEO of TAP Biosystems) | Managing Director | SPT Labtech (Group) | United Kingdom (GB) |
Newcombe-Ellis, Alice (Ahren Innovation Capital 201902 Managing Partner + Founder) | Managing Partner (investment firm) | Ahren (Group) | United Kingdom (GB) |
Newcombe-Ellis, Matthew (Ahren 202208 Operating Partner at Ahren Commercial Engine) | Partner (venture partner) | Ahren (Group) | United Kingdom (GB) |
Newland, Andrew (Angle plc 201409 CEO + Founder) | Chief Executive Officer (CEO) | Angle plc (AIM: AGL) | United Kingdom (GB) |
Newman, Kasia (Abcam 200910 European Marketing Coordinator) | Sales Manager / Marketing Manager | Abcam (Group) | United Kingdom (GB) |
Newton, Chris (BioFocus 200808 Senior VP) | n. a. | Charles River (Group) | United Kingdom (GB) |
Ney, Ursula M. (Genkyotex 201105– CEO before Antisoma COO before Charterhouse Therapeutics CEO) | Chief Executive Officer (CEO) | Calliditas Therapeutics (Group) | Switzerland |
Nguyen, Tran (Prothena 201701 CFO) | Chief Financial Officer (CFO) | Prothena (Group) | Ireland, Republic of |
Nicholds, Mike (Newcells Biotech 202102 CEO) | Chief Executive Officer (CEO) | Newcells Biotech Ltd. | United Kingdom (GB) |
Nicholl, Colin (Microsaic 201307–201701 Board Chairman before Deputy Chairman RETIRED 1/17) | Board member, non-executive | Microsaic Systems plc (AIM: MSYS) | United Kingdom (GB) |
Nichols, Ben (Alveron Pharma 201903– CEO before Haemostatix + Plasso Technology) | Chief Executive Officer (CEO) | Alveron Pharma B.V. | Netherlands |
Nicholson, David (Allergan 201604 EVP + President Global Brands RnD) | Research & Development Manager | Allergan (Group) | Ireland, Republic of |
Nicholson, Ian (F2G Ltd 201303– CEO + Partner at Advent Life Sciences before Chroma Therapeutics CEO + Celltech + OGS) | Chief Executive Officer (CEO) | F2G (Group) | United Kingdom (GB) |
Nicholson, Jeremy (Murdoch Univ + ANPC 201909 Prof before Imperial College + MRC-NIHR Phenome Centre) | Professor | Murdoch University | Australia |
Nicklasson, Martin (Biovitrum 200505– CEO before AstraZeneca AB CEO before Astra before Kabi Pharmacia) | Chief Executive Officer (CEO) | Swedish Orphan Biovitrum (Sobi) (Group) | Sweden |
Nicklin, Simon (GRI –200710– Managing Director) | Managing Director | Genetic Research Instrumentation (GRI) (Group) | United Kingdom (GB) |
Nielsen, Debra (Immunocore 202102 Head of Communications) | Public Relations Manager / Investor Relations Manager | Immunocore Holdings plc (Nasdaq: IMCR) | United Kingdom (GB) |
Nielsen, Fiona (Repositive 201608 CEO) | Chief Executive Officer (CEO) | Repositive (GB) | United Kingdom (GB) |
Nielsen, Jack B. (Novo Capital 202101 formerly 201411 Partner at Novo Ventures) | Partner (venture partner) | Vivo Capital (US/CN) | United States (USA) |
Nielsen, Jens (BioInnovation Institute 202012– CEO) | Chief Executive Officer (CEO) | BioInnovation Institute (BII Foundation) | Denmark |
Nielsen, Nicolaj (Inprother ApS 201912 CFO) | Chief Financial Officer (CFO) | InProTher ApS | Denmark |
Nielsen, Peder Holk (Novo Group 201407 CEO of Novozymes) | Chief Executive Officer (CEO) | Novozymes (Group) | Denmark |
Nielsen, Søren (Action Pharma 200902 CEO) | Chief Executive Officer (CEO) | CPTone Biotech ApS | Denmark |
Nieminen, Antti (Biovian 202303 CEO + Co-Founder) | Chief Executive Officer (CEO) | Biovian Oy | Finland |
Nilsen, Jørgen André (Telenor 201210 Televenture) | Chief Executive Officer (CEO) | APIM Therapeutics AS | Norway |
Nilsson, Jan (CombiGene 201610– CEO before NeuroVive + Pergamum + Tripep) | Chief Executive Officer (CEO) | CombiGene AB | Sweden |
Nilsson, Magnus (Vitrolife –200801– CEO) | Chief Executive Officer (CEO) | Vitrolife (Group) | Sweden |
Nilsson, Mats (Univ Stockholm 202010 SciLife Lab) | Researcher (university / research institute) | SciLifeLab (Science for Life Laboratory) | Sweden |
Nilsson, Stefan K. (Lipigon Pharmaceuticals AB 201603 CEO) | Chief Executive Officer (CEO) | Lipigon Pharmaceuticals AB | Sweden |
Nilsson, Åke (Saga Diagnostics 201803– Director Corporate + Business Development) | Business Development Manager / Strategy Manager | Saga Diagnostics AB | Sweden |
Nisbet, Louis J. (BioCity Nottingham 201201 Chairman of BioCity Scotland Ltd) | Board member | Pioneer Group, The (WAPG) (Group) | United Kingdom (GB) |
Nisbet-Fahy, Julia (The Binding Site 201608 before Bio-Rad 201307 Business Unit Marketing Manager at AbD Serotec) | Sales Manager / Marketing Manager | Thermo Fisher (Group) | United Kingdom (GB) |
Noble, James (Adaptimmune 201909– Non-Executive Director before CEO before MediGene + Avidex) | Board member, non-executive | Adaptimmune (Group) | United Kingdom (GB) |
Nolan, Peter (Oxford BioMedica 200507) | n. a. | Oxford Biomedica (Group) | United Kingdom (GB) |
Nonhoff, Offer (Pixium Vision 202106– CFO before Trigo + Lumenis + BoneSupport + Fresenius Medical Care Israel) | Chief Financial Officer (CFO) | Pixium Vision S.A. | France |
Noonan, Mo (Mo PR Advisory 202005– Founder before 21y at FTI Consulting) | Public Relations Manager / Investor Relations Manager | Mo PR Advisory Ltd. | United Kingdom (GB) |
Noonan, Rebecca (Optimum Stratetic Communications 202206) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | United Kingdom (GB) |
Noone, Philip (Aalto Bio Reagents 202205 CEO) | Chief Executive Officer (CEO) | Biosynth (since 9/22) (Group) | Ireland, Republic of |
Noorem, Toomas (Tartu Science Park 201110 Managing Director) | Managing Director | Tartu Science Park Foundation | Estonia |
Nordkild, Peter (Adenium Biotech 2011– CEO before Egalet CEO before Pharmexa COO before Ferring Senior VP) | Chief Executive Officer (CEO) | Adenium Biotech ApS | Denmark |
Nordlander, Rune (Sprint Bioscience 201906 Board Chairman) | Board member, non-executive | Sprint Bioscience AB | Sweden |
Nordstedt, Christer (Oblique Therapeutics 202311 CEO before Vivesto) | Chief Executive Officer (CEO) | Oblique Therapeutics AB (publ) | Sweden |
Norgaard, Jens Viktor (Symphogen 200705 Director IP) | IP Manager | Servier (Group) | Denmark |
Norgren, Niklas (UmanDiagnostics 201906 CEO) | Chief Executive Officer (CEO) | Quanterix (Group) | Sweden |
Norlén, Per (Alligator Bioscience –202103 CEO) | Chief Executive Officer (CEO) | Alligator Bioscience (Group) | Sweden |
Norman, John (Optibrium 202002 Head of Marketing) | Sales Manager / Marketing Manager | Optibrium (Group) | United Kingdom (GB) |
Norrey, Martin (European Spectrometry Systems founder) | Company Founder | European Spectrometry Systems Ltd. (ESS) | United Kingdom (GB) |
Northage, Alan (Shimadzu 201112 Shimadzu UK GC/GCMS Business Manager) | Product Manager (personnel) | Shimadzu (Group) | United Kingdom (GB) |
Norwood, David (IP2IPO 200506 CEO) | Chief Executive Officer (CEO) | IP Group (Group) | United Kingdom (GB) |
Novoselov, Kostya (Univ Manchester 201504 Nobel Prize for Physics in 2010) | Professor | University of Manchester, National Graphene Institute (NGI) | United Kingdom (GB) |
Nowers, Chris (Cell Medica 201808– CEO before Kite Pharma 201610– Head of Europe before BMS + Genomic Health) | Chief Executive Officer (CEO) | Athenex (Group) | United Kingdom (GB) |
Nurmi, Virve (Biotie 201110 Investor Relations Manager) | Public Relations Manager / Investor Relations Manager | Acorda Therapeutics (Group) | Finland |
Nurse, Paul (Francis Crick Institute 201602 Director) | President/Director/Head of Research Organisation/Unit | Francis Crick Institute Ltd., The | United Kingdom (GB) |
Nussbaumer, Oliver (GammaDelta Therapeutics Co-Founder) | Company Founder | Takeda (Group) | United Kingdom (GB) |
Nygård, Mikael (Vicore Pharma 202111– VP of Business Development before Humana AB + Boston Consulting Group) | Business Development Manager / Strategy Manager | Vicore Pharma (Group) | Sweden |
Nyström, Mattias (APL 201608 Business Development Manager) | Business Development Manager / Strategy Manager | APL (SE) (Group) | Sweden |
Närhi, Jari (Nadmed 202402 CEO + Co-Founder) | Chief Executive Officer (CEO) | Nadmed Oy | Finland |
Næss-Ulseth, Eirik (Spermatech 200803 CEO) | Chief Executive Officer (CEO) | Spermatech AS | Norway |
Näsström, Jacques | n. a. | Karolinska Investment Fund | Sweden |
Näveke, Arne (Consilium 202303– Senior Strategic Advisor + head of US before Freeline Therapeutics + Alexion + GSK) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United States (USA) |
O'Brien, Elaine (Camena Bioscience 202307 Head of Marketing before Horizon Discovery) | Sales Manager / Marketing Manager | Camena Bioscience Ltd. | United Kingdom (GB) |
Oakland, Simon Nicholas (Biofusion 200604 non-exec Director) | Board member, non-executive | Fusion IP (Group) | United Kingdom (GB) |
Oakley, Andrew J. (Autolus 201806– CFO before Sosei + Vectura + Novimmune + Actelion) | Chief Financial Officer (CFO) | Autolus Therapeutics plc (Nasdaq: AUTL) | United Kingdom (GB) |
Oakman, Colin (Healx 201807 Finance Director) | Chief Financial Officer (CFO) | Healx Ltd. | United Kingdom (GB) |
Obstoj-Cardwell, Barbara (The Pharma Letter 2009– Managing Editor before IMS Health + Founding Editor of Scrip) | Editor / Publisher | Pharma Letter Ltd., The | United Kingdom (GB) |
Odell, Antony (Tissue Regenix 201112 Managing Director) | Managing Director | Tissue Regenix Group plc | United Kingdom (GB) |
Odgaard, Katie (Zyme Communications 201108 Senior Account Manager before College Hill Life Sciences) | Public Relations Manager / Investor Relations Manager | Zyme Communications Ltd. | United Kingdom (GB) |
Odlander, Björn (HealthCap 200406 Managing Director + Jerini Board Member) | Managing Director | Odlander Fredrikson (Group) | Sweden |
Oelkers, Guido (Swedish Orphan Biovitrum 201705– CEo before BSN Medical GmbH + Nycomed) | Chief Executive Officer (CEO) | Swedish Orphan Biovitrum (Sobi) (Group) | Sweden |
Oerlemans, Quentin (Coulter Partners 201805– Senior Consultant before Egon Zehnder + Coulter Partners) | consulting (economic) | Coulter Partners (The Coulter Partnership Ltd.) | United Kingdom (GB) |
Offin, Phil (Automation Partnership 200209 Cell Biology Application Manager) | Product Manager (personnel) | Sartorius (Group) | United Kingdom (GB) |
Ohlson, Jonny (Touchlight Genetics 201606 CEO) | Chief Executive Officer (CEO) | Touchlight (Group) | United Kingdom (GB) |
Ohlsson, Jonas (Cellectricon 200804– CEO before Mentice CEO before PE Applied Biosystems + Kovalent AB + AstraZeneca) | Chief Executive Officer (CEO) | Cellectricon (Group) | Sweden |
Oinonen, Tero (4Pharma 202306 CEO) | Chief Executive Officer (CEO) | BC Platforms (BCP) (Group) | Finland |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top